Bertino, Enrico

Biolatti, Matteo

DE ANDREA, Marco

Dell’Oste, Valentina

Galitska, Ganna

Landolfo, Santo

English

Institutional Research Information System University of Turin

16 October 2023AperTO - Archivio Istituzionale Open Access dell'Università di TorinoOriginal Citation:A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligandsimmunomodulationTerms of use:Open Access(Article begins on next page)Anyone can freely access the full text of works made available as "Open Access". Works made availableunder a Creative Commons license can be used according to the terms and conditions of said license. Useof all other works requires consent of the right holder (author or publisher) if not exempted from copyrightprotection by the applicable law.Availability:This is the author's manuscriptThis version is available http://hdl.handle.net/2318/1712501 since 2019-09-30T12:16:05Z  A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation VALENTINA DELL’OSTEa, GANNA GALITSKAb, MATTEO BIOLATTIa, SIMONE DE MEOb, AGATA LEONEc, ENRICO BERTINOc, RACHELE CAGLIANId, DIEGO FORNId, MANUELA SIRONId, LARS STEINBRUECKe, THOMAS SCHULZe, MARCO DE ANDREAa,f, ANGELA SANTONIb, CRISTINA CERBONIb, , AND SANTO LANDOLFOa a Department of Public Health and Pediatric Sciences, Laboratory of Pathogenesis of Viral Infection, University of Turin, Turin, Italy; b Department of Molecular Medicine, Laboratory of Molecular Immunology and Immunopathology, "Sapienza" University of Rome, 00161 Rome, Italy; c Department of Public Health and Pediatric Sciences, Neonatal Unit, University Hospital of Turin, Turin, Italy; d Scientific Institute IRCCS E. Medea, Bioinformatic Laboratory, Bosisio Parini, Italy; e Hannover Medical School, Institute of Virology, Hannover, Germany; f Center for Translational Research on Autoimmune and Allergic Disease - CAAD, University of Piemonte Orientale, Novara, Italy.  Introduction. Human cytomegalovirus (HCMV) is the leading cause of congenital infection resulting in severe morbidity and mortality among infected newborns worldwide; however, mechanisms and virulence factors contributing to HCMV pathogenesis and particular clinical outcomes remain unclear. To successfully establish a persistent infection, the virus must have evolved multiple mechanisms to avoid host immune recognition. For example, HCMV infected cells exhibit remarkable resistance to natural killer (NK) cell-mediated cytolysis via encoding a large set of immunomodulatory proteins. Furthermore, HCMV demonstrates an exceptionally high degree of variability. Against this background, our aim was to determine whether and to what extent the differences in genetic composition affects viral fitness, its ability to modulate NK response, and clinical outcome.  Materials and Methods. For this purpose, we enrolled a cohort of 21 pediatric patients with confirmed HCMV congenital infection. We evaluated the degree of genetic polymorphism of HCMV clinical strains by next generation sequences (NGS), primarily focusing on viral genes known to encode proteins with potent NK immunomodulatory functions. In parallel, we ran an extensive in vitro analysis of all clinical isolates to characterize viral growth properties in different cellular models.  Results. Here we report extraordinary genetic and phenotypic diversity of the clinical isolates, reflected in both viral growth properties and ability to modulate NK cells. Growth analysis of HCMV clinical isolates revealed different patterns of replication and dissemination. Although we observed no difference in cell tropism, the fast-replicative isolates form a unique morphological pattern. The analysis of NK cell activating ligands at both RNA and protein level, demonstrated that HCMV clinical strains affect NK ligands to different degrees. For instance, all viruses downmodulate ULBP2/5/6 ligand, with the strongest effect observed with the phenotypically more aggressive isolates. Moreover, there was a strong up-regulation of PVR observed with fast-replicative isolates. Conversely, other NK ligands, such as MICA, MICB, ULBP3 and B7-H6, were not modulated by any of the HCMV isolates. Finally, to assess whether HCMV isolates affect NK recognition, we analyzed IFN-gamma production. Likewise, we observed a great variation between clinical strains, indicating that the genetic variability actually reflects variability in functionality.    Discussion and Conclusions. Overall, our study contributes to understanding the impact of viral genetic variability on viral fitness and immune system modulation, with the ultimate goal to identify valuable markers for the management of congenitally infected newborns.  Keywords: Human cytomegalovirus (HCMV), congenital infection, clinical isolates, genetic variability, viral phenotypes, immunomodulation, NK ligands. 

A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation

https://iris.unito.it/bitstream/2318/1712501/3/Dell%27Oste%20Abstract%20SIM%202019.pdf

A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation

Abstract

Similar works

Full text

Available Versions

Institutional Research Information System University of Turin